Connect with us

Newsletter

Stock Price Newsletter – Breaking News & Articles For March 20, 2019

Joe Samuel

Published

on

Premier Health (OTC:P​HGRF) (CSE:P​HGI) Launching Virtual and Remote Medical Services

VANCOUVER, British Columbia, March 20, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it will be launching a range of virtual and remote services to be offered to primary care clinics, including Nurses,  Medical Office Assistants (MOA) and Office Managers. The initial launch will focus on current Juno EMR clients in BC with plans to roll out to other provinces by the end of Q2 2019. Click Here And Read The Full Press Release

Where Is Healthcare Headed?

As the global population begins to both increase in number and age, more and more people are in need of personalized healthcare and treatment tailored to their specific needs. Diseases have become far too advanced for patients to take a “one-pill-cures-all” treatment and hope for the best. Medical experts and scientists are actually looking at a patient’s genetic makeup to determine how to best treat each individual person.  Click Here To Read More

Google Stadia Is More Than It Streams

Moving on, it’s safe to say that there are few, if any, people in the world that haven’t heard of Google (GOOGL). The Company created a search engine which has since revolutionized how we ascertain information, as well as how businesses reach out to consumers. During that time, Google (GOOGL) has been given a home in the Oxford English Dictionary, as well as expanded its operations to far more than an internet-powered encyclopedia on everything anyone could ever know. We’ve seen Google Maps (GOOGL), Google’s own smartphone, the Pixel, and countless other innovations from the gargantuan tech company.  Read More Here.


 

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC  and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). Midam has been compensated an additional $100,000 by Premier Health Group to extend the period of coverage to June 1, 2019. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Continue Reading
Click to comment

Featured

Stock Price Morning Update – July 22, 2019

Joe Samuel

Published

on

Gold Prices Have Investors Scrambling & Analysts Clamoring For Junior Gold Stocks

Gold has long been a safe haven stock. But as the market turned toward tech, precious metal stocks took a back seat…until now. Could the timing of gold’s next bull run be perfect right now?

Continue Reading


PharmaCyte Biotech (PMCB) and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes

PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced it has entered into a new research agreement with the University of Technology Sydney (UTS) in Australia to create a new version of Melligen cells for the treatment of diabetes with the potential to express higher levels of insulin.

Read The Full Release


ROKU Stock Price Hits Another Life Time High: Good News For Tech Stocks?

In 2019 alone, the stock has risen by as much as 271% as the company continued to add new customers and boosted revenues from advertising. However, could the latest surge be a signal for the next bull market in tech?

See For Yourself


Two Massive Growth Industries, One Choice for Investors

These two industries are at the epicenter of growth and investors aren’t being shy about their appetite for companies in these arenas. But one company, in particular, has developed a unique business model that services both of these massive growth industries.

Click To Read More


adbe stock price twlo stock price

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Friday Update – July 19, 2019

Joe Samuel

Published

on

stock market news July

ROKU Stock Price Hits Another Life Time High: Good News For Tech Stocks?

In 2019 alone, ROKU stock has risen by as much as 271% as the company continued to add new customers and boosted revenues from advertising. However, could the latest surge be a signal for the next bull market in tech?

See For Yourself


3 Biotech Stocks To Watch After Big News This Month

Here is a look at 3 biotechnology stocks that proved to be winners recently.

Click Here To Read More


IPO News: Medallia Goes Public On Friday, July 19

Over 14 million shares of the company will be available to be traded at $16 to $18 per share on NYSE. And of course, investors will be watching MDAL stock price closely. Bank of America Merrill Lynch, Citigroup, and Wells Fargo Securities will oversee the IPO.

Click Here For Full Article

Continue Reading

Featured

Stock Market Must Read Update For July 17, 2019

Jon Phillip

Published

on

stock price newsletter

3 Biotech Stocks To Watch After Big News This Month

If there is one sector that has grown immensely strong over the past decade and a half, then it’s biotech. These biotech stocks and underlying companies have come up with highly innovative solutions to a range of diseases. Furthermore, it has been through the use of technology and knowledge of pharmaceuticals, which has added to the innovation.

Read More Here


There’s A New Way To Netflix & Chill In The Stock Market

One Company That’s Already Breaking Into The Global On-Demand Industry At A Rapid Pace…SPECIAL REPORT

Click To Read More


Netflix Stock Price: A Big Week For The Investors, All Eyes on Earnings

If there is one company which has managed to change the very face of entertainment, it’s Netflix Inc. It has done it by making online streaming the preferred medium for millions around the world. As earnings season begins, the most anticipated second-quarter report this week is going to be from Netflix. The company will publish its earnings today.

See For Yourself


FANG Stocks Gaining Momentum, What Should You Do Now?

During the first half of 2018, FANG stocks reached their peak and then entered a period of consolidation. However, these four stocks have made a roaring comeback this year. Each of those four tech stocks has beaten the S&P 500 comfortably in 2019 thus far.

Continue Reading

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com